The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells

Stem Cells and Development

Volumn 21, Issue 3, 2012, Pages 455-464

  Hirvonen, Tia ^a   Suila, Heli ^a   Kotovuori, Annika ^a   Ritamo, Ilja ^a   Heiskanen, Annamari ^b   Sistonen, Pertti ^a   Anderson, Heidi ^a   Satomaa, Tero ^b   Saarinen, Juhani ^b   Tiitinen, Sari ^a   Räbinä, Jarkko ^a   Laitinen, Saara ^a   Natunen, Suvi ^a   Valmu, Leena ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b GLYKOS FINLAND LTD   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP I ANTIGEN; CELL SURFACE MARKER; EPITOPE; GALECTIN 3; GLYCAN; LECTIN; LIGAND; N ACETYLGLUCOSAMINYLTRANSFERASE;

ARTICLE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

AMINO SUGARS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EPITOPES; FETAL BLOOD; FLOW CYTOMETRY; GALECTIN 3; GENE EXPRESSION PROFILING; HUMANS; I BLOOD-GROUP SYSTEM; LIGANDS; MASS SPECTROMETRY; MESENCHYMAL STEM CELLS; N-ACETYLGLUCOSAMINYLTRANSFERASES; STEM CELL NICHE;

EID: 84856705647     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0405     Document Type: Article

References (55)

1. Moore KE, JF Mills and MM Thornton. (2006). Alternative sources of adult stem cells: a possible solution to the embryonic stem cell debate. Gend Med 3:161-168. (Pubitemid 44636943)
2. Pessina A and L Gribaldo. (2006). The key role of adult stem cells: therapeutic perspectives. Curr Med Res Opin 22:2287-2300. (Pubitemid 44789992)
3. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74. (Pubitemid 27161245)
4. Porada CD, ED Zanjani and G Almeida-Porad. (2006). Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 1:365-369.
5. Wang M, Y Yang, D Yang, F Luo, W Liang, S Guo and J Xu. (2009). The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:220-232.
6. Sioud M. (2011). New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins. Scand J Immunol 73:79-84.
7. Lu LL, YJ Liu, SG Yang, QJ Zhao, X Wang, W Gong, ZB Han, ZS Xu, YX Lu, D Liu, ZZ Chen and ZC Han. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026.
8. Kern S, H Eichler, J Stoeve, H Klüter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301. (Pubitemid 44464698)
9. Brooke G, M Cook, C Blair, R Han, C Heazlewood, B Jones, M Kambouris, K Kollar, S McTaggart, et al. (2007). Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18:846-858. (Pubitemid 350138458)
10. Malgieri A, E Kantzari, MP Patrizi and S Gambardella. (2010). Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 3:248-269.
11. Lanctot PM, FH Gage and AP Varki. (2007). The glycans of stem cells. Curr Opin Chem Biol 11:373-380. (Pubitemid 47302845)
12. Muramatsu T and H Muramatsu. (2004). Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J 21:41-45. (Pubitemid 39360739)
13. Wright AJ and PW Andrews. (2009). Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res 3:3-11.
14. Badcock G, C Pigott, J Goepel and PW Andrews. (1999). The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res 59:4715-4719. (Pubitemid 29428981)
15. Schopperle WM and WC DeWolf. (2007). The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25:723-730. (Pubitemid 46354232)
16. Suila H, V Pitkanen, T Hirvonen, A Heiskanen, H Anderson, A Laitinen, S Natunen, H Miller-Podraza, T Satomaa, et al. (2011). Are globoseries glycosphingolipids SSEA-3 and -4 markers for stem cells derived from human umbilical cord blood? J Mol Cell Biol 3:99-107.
17. Natunen S, T Satomaa, V Pitkanen, H Salo, M Mikkola, J Natunen, T Otonkoski and L Valmu. (2011). The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency associated type 1 lactosamine epitope. Glycobiology 21:1125-1130.
18. Heiskanen A, T Hirvonen, H Salo, U Impola, A Olonen, A Laitinen, S Tiitinen, S Natunen, O Aitio, et al. (2009). Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 26:367-384.
19. Renkonen O. (2000). Enzymatic in vitro synthesis of Ibranches of mammalian polylactosamines: generation of scaffolds for multiple selectin-binding saccharide determinants. Cell Mol Life Sci 57:1423-1439.
20. Rabinovich GA and MA Toscano. (2009). Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338-352.
21. Kekarainen T, S Mannelin, J Laine and T Jaatinen. (2006). Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol 7:30.
22. Jaatinen T and J Laine. (2007). Isolation of mononuclear cells from human cord blood by Ficoll-Paque density gradient. Curr Protoc Stem Cell Biol Chapter 2:Unit 2A.1.
23. Laitinen A, J Nystedt and S Laitinen. (2011). The isolation and culture of human cord blood-derived mesenchymal stem cells under hypoxic conditions. In Mesenchymal Stem Cell Assays and Applications Vemuri M, LG Chase, MS Rao, eds. Humana Press, New York, pp 63-74.
24. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
25. Yu LC, YC Twu, ML Chou, ME Reid, AR Gray, JM Moulds, CY Chang and M Lin. (2003). The molecular genetics of the human I locus and molecular background explain the partial association of the adult i phenotype with congenital cataracts. Blood 101:2081-2088. (Pubitemid 36302039)
26. Dai M, P Wang, AD Boyd, G Kostov, B Athey, EG Jones, WE Bunney, RM Myers, TP Speed, et al. (2005). Evolving gene/ transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175.
27. Dai M, P Wang, E Jakupovic, SJ Watson and F Meng. (2007). Web-based GeneChip analysis system for large-scale collaborative projects. Bioinformatics 23:2185-2187. (Pubitemid 47394122)
28. Wu Z and RA Irizarry. (2004). Preprocessing of oligonucleotide array data. Nat Biotechnol 22:656-658.
29. Kinter M and NE Sherman. (2000). Protein Sequencing and Identification Using Tandem Mass Spectrometry. In: Protein Sequencing and Identification using Tandem Mass Spectrometry Kinter M, NE Sherman, eds. John Wiley & Sons, Inc., New York, pp 160-163.
30. Kang P, YMechref andMVNovotny. (2008). High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom 22:721-734. (Pubitemid 351373956)
31. UniProt Consortium. (2010). The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38:D142-D148.
32. Ceroni A, K Maass, H Geyer, R Geyer, A Dell and SM Haslam. (2008). GlycoWorkbench: a tool for the computerassisted annotation of mass spectra of glycans. J Proteome Res 7:1650-1659.
33. Niemann H, K Watanabe and S Hakomori. (1978). Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: the structural requirements for i-specificities. Biochem Biophys Res Commun 81:1286-1293. (Pubitemid 8331488)
34. Yousefi S, E Higgins, Z Daoling, A Pollex-Krüger, O Hindsgaul and JW Dennis. (1991). Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-Nacetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. J Biol Chem 266:1772-1782. (Pubitemid 21908368)
35. MaemuraKandMFukuda. (1992). Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. J Biol Chem 267:24379-24386.
36. van den Eijnden DH, AH Koenderman and WE Schiphorst. (1988). Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc: N-acetyllactosaminide beta 1-3-N- acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid. J Biol Chem 263: 12461-12471. (Pubitemid 19000427)
37. Pierce M and J Arango. (1986). Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J Biol Chem 261:10772-10777. (Pubitemid 17194865)
38. Henion TR, D Zhou, DP Wolfer, FB Jungalwala and T Hennet. (2001). Cloning of a mouse beta 1,3 N-acetylglucosaminyltransferase GlcNAc(beta 1,3)Gal(beta 1,4) Glc-ceramide synthase gene encoding the key regulator of lacto-series glycolipid biosynthesis. J Biol Chem 276:30261-30269.
39. Togayachi A, T Akashima, R Ookubo, T Kudo, S Nishihara, H Iwasaki, A Natsume, H Mio, J Inokuchi, et al. (2001). Molecular cloning and characterization of UDP-GlcNAc: lactosylceramide beta 1,3-N- acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem 276:22032-22040.
40. Togayachi A, Y Kozono, Y Ikehara, H Ito, N Suzuki, Y Tsunoda, SAbe, T Sato,KNakamura, et al. (2010). Lack of lacto/ neolacto-glycolipids enhances the formation of glycolipidenriched microdomains, facilitating B cell activation. Proc Natl Acad Sci U S A 107:11900-11905.
41. Bierhuizen MF and M Fukuda. (1992). Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci U S A 89:9326-9330.
42. Saito H, A Nishikawa, J Gu, Y Ihara, H Soejima, Y Wada, C Sekiya, N Niikawa and N Taniguchi. (1994). cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+ . Biochem Biophys Res Commun 198: 318-327.
43. Amado M, R Almeida, T Schwientek and H Clausen. (1999). Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1473:35-53.
44. Guo S, T Sato, K Shirane and K Furukawa. (2001). Galactosylation of N-linked oligosaccharides by human beta-1, 4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11:813-820. (Pubitemid 32982662)
45. Sasaki K, K Kurata-Miura, M Ujita and K Furukawa. (1997). Expression cloning of cDNA encoding a human beta-1,3-Nacetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc Natl Acad Sci U S A 94:14294-14299.
46. Zhou D, A Dinter, R Gutierrez Gallego, JP Kamerling, JF Vliegenthart, EG Berger and T Hennet. (1999). A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1, 3-galactosyltransferases. Proc Natl Acad Sci U S A 96:406-411. (Pubitemid 29061221)
47. Shiraishi N, A Natsume, A Togayachi, T Endo, T Akashima, Y Yamada, N Imai, S Nakagawa, S Koizumi, et al. (2001). Identification and characterization of three novel beta 1,3-Nacetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family. J Biol Chem 276:3498-3507.
48. Kitayama K, Y Hayashida, K Nishida and TO Akama. (2007). Enzymes responsible for synthesis of corneal keratan sulfate glycosaminoglycans. J Biol Chem 282:30085-30096. (Pubitemid 350035267)
49. Ishida H, A Togayachi, T Sakai, T Iwai, T Hiruma, T Sato, R Okubo, N Inaba, T Kudo, et al. (2005). A novel beta1,3-Nacetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett 579:71-78. (Pubitemid 40023376)
50. Stowell SR, CM Arthur, P Mehta, KA Slanina, O Blixt, H Leffler, DF Smith and RD Cummings. (2008). Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283:10109-10123.
51. Beyer Nardi N and L da Silva Meirelles. (2006). Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249-282.
52. Marsh WL. (1961). Anti-i: a cold antibody defining the Ii relationship in human red cells. Br J Haematol 7:200-209.
53. Fukuda M, MN Fukuda and S Hakomori. (1979). Developmental change and genetic defect in the carbohydrate structure of band 3 glycoprotein of human erythrocyte membrane. J Biol Chem 254:3700-3703. (Pubitemid 9178781)
54. Ujita M, J McAuliffe, M Suzuki, O Hindsgaul, H Clausen, MN Fukuda and M Fukuda. (1999). Regulation of I-branched poly-N-acetyllactosamine synthesis. Concerted actions by I-extension enzyme, I-branching enzyme, and beta 1,4-galactosyltransferase I. J Biol Chem 274:9296-9304.
55. Thomas DB. (1974). The i antigen complex: a new specificity unique to dividing human cells. Eur J Immunol 4:819-824.